P2.06-29 Expression of Estrogen Receptor Beta (ERb) and Its Prognostic Value in the Pleural Mesothelioma.

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1284
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.06-13 Poor Nutritional Status Is a Poor Prognostic Factor in Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.06-37 Four Immunohistochemical Assays to Measure the PD-L1 Expression in Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.06-15 Malignant Pleural Mesothelioma in Young Adult People in Uganda

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P21: Prognostic Marker in Pleural Mesothelioma

Molecular Pathology
2002English

Prognostic Factors in Patients With Malignant Pleural Mesothelioma

International Journal of Biomedicine
2015English

P2.06-35 Pleurectomy Decortication Versus Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma: SPARCS Data

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.06-27 Extrapleural Pneumonectomy, Radiation Therapy, and Chemotherapy for Epithelioid Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.06-12 Improving Quality of Care for Pleural Mesothelioma: 2018 National Mesothelioma Audit Results for England and Wales

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.06-14 Does Size Matter? A Population-Based Analysis of Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy